Covalently Stabilized Alginate-PAG Coatings for Cell Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for cellular encapsulation using alginate and PEG-based gels are unstable, leading to degradation and inadequate nutrient delivery for metabolically active cells, and often cause cell damage due to oxidative stress.
Innovation Solution
A biocompatible capsule with a covalently stabilized coating formed by reacting alginate-polyalkylene glycol (PAG) and multi-functional PAG molecules to create covalent bonds, allowing for the formation of molecular monolayers that encapsulate cells without using free-radical initiators, thereby preventing cell damage and enhancing stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If alginate gels are used for cellular encapsulation, then biocompatibility is improved, but stability deteriorates due to degradation over time
Solution Approach 1:
The patent creates a composite encapsulation system combining alginate (for biocompatibility) with PEG-based polymers and cross-linking agents (for stability). The alginate provides the biocompatible barrier while the PEG cross-linked network provides structural stability, resolving the contradiction between biocompatibility and stability.
Solution Approach 2:
The patent modifies the chemical structure of alginate by introducing cross-linking parameters (changing from linear to cross-linked polymer network) and adjusting PEG molecular weight and concentration. These parameter changes transform the unstable alginate gel into a stable cross-linked hydrogel while maintaining biocompatibility.
2Object-affected harmful factors
If alginate gels are used for cellular encapsulation, then cell protection is improved, but nutrient delivery deteriorates due to inadequate diffusion
Solution Approach 1:
The patent creates local quality differences within the encapsulation matrix by incorporating PEG chains with specific hydrophilicity and porosity characteristics. This allows the coating to provide cell protection at the cellular level while maintaining adequate nutrient and oxygen diffusion pathways, resolving the contradiction between protection and nutrient delivery.
3Stability of the object's composition
If covalent cross-linking is used to stabilize alginate gels, then stability is improved, but cell damage increases due to oxidative stress
Solution Approach 1:
The patent uses PEG as an intermediary substance that mediates between the alginate cross-linking process and the cells. The PEG forms a protective hydrophilic network that allows controlled cross-linking while preventing direct contact between cross-linking agents and cells, thereby reducing oxidative stress and cell damage while achieving gel stability.
Solution Approach 2:
The patent changes the cross-linking parameters by using PEG-based cross-linking mechanisms instead of traditional heavy metal cross-linkers, and by controlling cross-linking density through PEG concentration and molecular weight. These parameter changes achieve gel stability while minimizing cell damage from oxidative stress.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides a stable and biocompatible coating that prevents immune rejection and ensures nutrient delivery to encapsulated cells, as demonstrated by the survival of human and Lewis rat islets for over eight days with minimal cell death.
Implementation Method 1
reacting (i) alginate-[polyalkylene glycol (PAG)-X1]n, and (ii) multi-functional PAG-X2, to form covalent bonds
Data Source
AI summary
A biocompatible capsule comprising a biological material encapsulated by a covalently stabilized coating and a method of making the same are disclosed. The biological material can be a material selected from the group consisting of cells, such as islets of Langerhans, pharmaceuticals, and biological agents. The coating can be formed by reacting an alginate-[polyalkylene glycol (PAG)-X1]n, and a multi-functional PAG-X2, to form covalent bonds, wherein n is an integer greater than 0, a first one of X1 and X2 is N3, and a second one of X1 and X2 is selected from the group consisting of:wherein R1=CH3, CH2CH3, CH(CH3)2,R2=N(CH3)2, OCH3, OH, CH3, H, F, Cl, Br or NO2, andR3=OCH3, CH3, H, F, Cl or NO2.